Alphatime Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders
21 déc. 2023 16h15 HE
|
AlphaTime Acquisition Corp.
New York, New York, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Alphatime Acquisition Corp (Nasdaq: ATMC, ATMCU, ATMCR, and ATMCW) (the “Company”) announced today that the Company’s Extraordinary General...
WinVest Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date
13 nov. 2023 07h45 HE
|
WinVest Acquisition Corp.
Cambridge, MA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- WinVest Acquisition Corp. (NASDAQ: WINV, the “Company”), a special purpose acquisition company, announced today that its Board of Directors (the...
Deep Medicine Acquisition Corp. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with TruGolf, Inc.
02 août 2023 20h55 HE
|
Deep Medicine Acquisition Corp.
SALT LAKE CITY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- – Deep Medicine Acquisition Corp. (NASDAQ: DMAQ) (“DMAQ” ), a publicly traded special purpose acquisition company, and TruGolf, Inc. ("TruGolf”), a...
TMT Acquisition Corp Announces the Separate Trading of its Ordinary Shares and Rights Commencing on May 1, 2023
27 avr. 2023 13h35 HE
|
TMT Acquisition Corp
New York, NY, April 27, 2023 (GLOBE NEWSWIRE) -- TMT Acquisition Corp (the “Company”) (Nasdaq: TMTCU), a blank check company incorporated as a Cayman Islands exempted company formed for the purpose...
TMT Acquisition Corp Announces Pricing of $60 Million Initial Public Offering
27 mars 2023 19h27 HE
|
TMT Acquisition Corp
New York, New York, March 27, 2023 (GLOBE NEWSWIRE) -- TMT Acquisition Corp (the “Company”), a newly incorporated blank check company incorporated as a Cayman Islands exempted company formed for the...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
22 mars 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
20 mars 2023 08h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
17 mars 2023 08h10 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Measures regarding Excise Tax
01 févr. 2023 17h43 HE
|
Aesther Healthcare Acquisition Corp.
NEW YORK and PROVIDENCE, R.I., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (SPAC) and Ocean Biomedical,...
Cetus Capital Acquisition Corp. Announces Pricing of $50,000,000 Initial Public Offering
31 janv. 2023 16h39 HE
|
Cetus Capital Acquisition Corp.
DELAWARE, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Cetus Capital Acquisition Corp. (the "Company") announced today that it priced its initial public offering of 5,000,000 units at $10.00 per unit. The...